Skip to main content

Fiscal Wizard · Single-issue tearsheet

MDT / Jun 22, 2026 Run #7697

MDT

Medtronic plc

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems and sensors, and InPen, a smart insulin pen. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.

Composite verdict

D 30.6 / 100
Bearish setup · Reversal 8 drivers · 2 gates blocking
  • ADX DI Cross
  • Chaikin Money Flow
  • Stochastic Cross
Consider long put target Δ ~0.70 · ~35 DTE Bearish setup, Grade A → ITM put target

Industry rank 45th of 141 in Medical Devices

rescore-sweep
Technical synthesisRegime: volatile downtrend
Bull 0%Evidence: High · 15 signals100% Bear
Momentum Bearish 16Mean-reversion Bearish 39
  • Late-stage trendTrend signals have been live for 80 bars — past the ~60-bar window; momentum edge decays and can reverse late in a move. (medium confidence)
Where value comes fromMargin of safety -46%
Asset value $37.52Earnings power value $24.79Price $79.34

Priced above its no-growth earnings power value ($24.79/share) — you're paying for growth and franchise expansion, not just current earnings.

Fundamentals Above average

59.4 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
EPS Growth (YoY) 100
Margin of Safety 0
Dividend Yield 83
OCF to Net Income 0
Total Shareholder Yield 82
Cash Conversion Cycle 0

Technicals Bearish

1.8 / 100

Bearish setup leads (ADX DI Cross, Chaikin Money Flow, Stochastic Cross); bulls gated by guards. · 43 signals shown.

Strongest
Weakest
ADX DI Cross 17
Chaikin Money Flow 17
Stochastic Cross 19

Risk Gates

2 blocking 6 caution

2 guards active, 26 signals gated.

Realized Volatility Regime Blocking

High-vol regime mutes mean-reversion signals; low-vol regime mutes breakout signals.

Regime Filter Blocking

Blocks signals that oppose the long-term moving-average regime.

Altman Z-Score Caution

Bottom-band Altman Z blocks bullish signals — distress risk.

Cash Ratio Caution

Visual cash-cushion flag — does not mute signals.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for MDT.